Cytostatic Drug Manufacturing – labCognition at ZIM Innovationstag

At ZIM Innovationstag, labcognition presents an analytical device for pharmacies that enables final verification of ingredients and dosage in parenteral preparations within the cytostatic drug manufacturing process.

Introducing CytoFortis

Here's what to expect on June 10th in Berlin

ZIM Innovationstag is Germany's largest innovation programme for SMEs, bringing together companies, research institutions, and funding bodies each year. On June 10th in Berlin, labCognition will present an analytical device - named CytoFortis - developed as part of a joint research project with IUTA. As part of a short pitch, we will introduce the device, its technology, and the vision behind it – and look forward to meeting visitors and having conversations on site.

The device delivers clear advantages for everyday lab use: the analysis is non-destructive and completed within seconds, integrates easily into existing processes, and requires minimal additional effort – while providing a substantial gain in safety, as every single preparation is verified individually.

Person in a laboratory places a cytostatic bag into the CytoFortis device — Non-destructive final verification directly in the infusion bag – completed within seconds with CytoFortis

As a novel device, CytoFortis is still in active development – which is precisely why direct exchange with practitioners is so valuable. Feedback from professionals who would use the device in their daily lab work feeds directly into its further development. We therefore particularly welcome conversations with pharmacies interested in trialling the device, as well as potential partners who would like to play an active role in shaping its future.

Back